{"date": "2021-08-09 04:07:30.043000+00:00", "ticker": "III", "mrkt_info": {"open": 1308.0, "close": 1337.0}, "html": "<div class=\"storyContent\" lang=\"fr\"><style type=\"text/css\">.storyContent * {border-color:inherit !important;outline-color:inherit !important;}</style><div class=\"tr-npp-lead\">\n<p>Liestal (awp) - Santhera a annonc\u00e9 le changement suivant au sein de son actionnariat, conform\u00e9ment au r\u00e8glement de la Bourse suisse (date de publication: 07.08.2021):</p>\n<p>awp-robot</p>\n</div>\n<div class=\"tr-npp-body\">\n<pre>actionnaire                   participation   naissance de    participation   \n                                   actuelle   l'obligation    ant\u00e9rieure    \n\nSanthera\n- positions d'achat                 3,06%      02.08.2021        7,28% \n- positions de vente               66,07%      02.08.2021       60,67%\n\nmotif: vente\n\nJPMorgan                           23,138%     03.08.2021      23,057%\n*dont nominatives 2,945%\n\nmotif: vente\n\nannonces pr\u00e9c\u00e9dentes:\n\nIdorsia Pharmaceuticals            21,29%      03.08.2021 \nJPMorgan                           23,057%     30.07.2021        \nJPMorgan                           23,8%       22.07.2021       \nJPMorgan                           23,773%     20.07.2021\nSanthera\n- positions d'achat                 7,28%      01.06.2021         \n- positions de vente               60,67%      01.06.2021   \nJPMorgan                           21,724%     01.06.2021\nSanthera\n- positions d'achat                16,81%      02.06.2021 \nJPMorgan                           31,572%     21.05.2021\nJPMorgan                           34,95%      20.05.2021        \nSanthera\n- positions d'achat                10,02%      19.05.2021           \n- positions de vente               77,54%      19.05.2021         \nUBS Fund Management                 4,45%      10.05.2021         \nSanthera\n- positions d'achat                 1,2%       10.05.2021            \n- positions de vente               84,3%       10.05.2021      \nOrbimed Genesis Master Fund, US     6,5%       07.05.2021       \nJPMorgan                           36,426%     10.05.2021\nJPMorgan                           45,325%     27.04.2021        \nJPMorgan                           44,22%      26.04.2021        \nSanthera Pharmaceuticals            \n- positions d'achat                 2,54%      22.04.2021     \n- positions de vente               97,72%      22.04.2021 \nSanthera Pharmaceuticals            \n- positions d'achat                 4,07%      19.04.2021          \n- positions de vente               94,17%      19.04.2021       \nJPMorgan                           24,72%      20.04.2021\nJPMorgan                           27,813%     12.04.2021         \nSanthera Pharmaceuticals            \n- positions d'achat                 6,54%      07.04.2021           \n- positions de vente               40,01%      07.04.2021       \nJPMorgan                           27,924%     08.04.2021 \nJPMorgan                           27,952%     07.04.2021 \nFabrice Evangelista, France\n- positions d'achat                   &lt;3%      07.04.2021         \nSanthera Pharmaceuticals            \n- positions d'achat                 6,54%      01.04.2021            \n- positions de vente               49,57%      01.04.2021         \nSanthera Pharmaceuticals            \nJPMorgan                           28,727%     30.03.2021            \nJPMorgan                          \n- positions d'achat                32,591%     26.03.2021       \nJPMorgan                          \n- positions d'achat                32,102%     24.03.2021\nJPMorgan                          \n- positions d'achat                33,041%     23.03.2021       \nSanthera Pharmaceuticals            \n- positions d'achat                 0,56%      19.03.2021             \n- positions de vente               56,99%      19.03.2021       \nJPMorgan\n- positions d'achat                33,274%     22.03.2021 \nJPMorgan\n- positions d'achat                33,418%     19.03.2021    \nJPMorgan\n- positions d'achat                34,114%     18.03.2021        \nSanthera Pharmaceuticals            \n- positions d'achat                 3,51%      09.03.2021\n- positions de vente               58,49%      09.03.2021\nJPMorgan                           35,743%     09.03.2021 \nJPMorgan                           35,37%      05.03.2021 \nJPMorgan                           37,857%     26.02.2021 \nSanthera Pharmaceuticals            \n- positions d'achat                 2,77%      26.02.2021      \n- positions de vente               60,92%     \nSanthera Pharmaceuticals  \n- positions d'achat                 4,13%      24.02.2021\n- positions de vente               61,51%                \nJPMorgan                           37,744%     24.02.2021            \nJPMorgan                           38,447%     22.02.2021                      \nJPMorgan                           37,891%     19.02.2021   \nJPMorgan                           35,576%     16.02.2021   \nJPMorgan                           29,843%     15.02.2021  \nSanthera Pharmaceuticals            \n- positions d'achat                 9,91%      15.02.2021  \n- positions de vente               51,68%      15.02.2021  \nJPMorgan                           27,249%     15.02.2021       \nJPMorgan                           11,202%     10.02.2021\nJPMorgan                           13,479%     08.02.2021 \nSanthera Pharmaceuticals            \n- positions d'achat                 9,97%      04.02.2021       \n- positions de vente               43,21%      04.02.2021      \nIdorsia Pharmaceuticals            22,94%      05.02.2021        \nJPMorgan                           19%         21.01.2021          \nJPMorgan                           20,756%     19.01.2021          \nSanthera Pharmaceuticals            \n- positions d'achat                 5%         13.01.2021        \nJPMorgan\n- positions d'achat                22,251%     12.01.2021\nJPMorgan\n- positions d'achat                23,445%     21.12.2020  \nJPMorgan\n- positions d'achat                24,715%     16.12.2020        \nJPMorgan\n- positions d'achat               25,007%      15.12.2020        \nJPMorgan\n- positions d'achat               26,375%      10.12.2020\nSanthera Pharmaceuticals            \n- positions d'achat                 9,91%      24.11.2020         \n- positions de vente               59,61%      24.11.2020        \nJPMorgan\n- positions d'achat               32,262%      18.11.2020       \nJPMorgan\n- positions d'achat               41,491%      18.11.2020   \nFabrice Evangelista, France\n- positions d'achat                14,83%      13.11.2020      \nJPMorgan\n- positions d'achat               41,491%      06.11.2020       \nSanthera Pharmaceuticals            \n- positions d'achat                 7,78%      01.11.2020         \n- positions de vente               85,05%      01.11.2020  \nJPMorgan, NY                      47,355%      01.11.2020 \nSanthera Pharmaceuticals            \n- positions d'achat                 8,46%      21.10.2020         \n- positions de vente                71,8%      21.10.2020        \ngroupe Bertarelli                   4,67%      23.10.2020        \nIdorsia Pharmaceuticals            29,24%      23.10.2020       \nJPMorgan, NY                      24,255%      07.10.2020 \nJPMorgan, NY                      22,997%      06.10.2020\nIdorsia Pharmaceuticals            22,34%      02.10.2020\nJPMorgan, NY                      21,661%      29.09.2020    \nJPMorgan, NY                      22,041%      28.09.2020    \nJPMorgan, NY                      22,935%      25.09.2020         \nFabrice Evangelista, Belgium\n- positions d'achat                24,98%      17.09.2020      \nSanthera Pharmaceuticals            \n- positions d'achat                 4,59%      14.09.2020         \n- positions de vente               58,42%      14.09.2020           \nIdorsia Pharmaceuticals            19,59%      16.09.2020 \nJPMorgan, NY                      24,035%      11.09.2020 \nJPMorgan, NY                      24,444%      07.09.2020   \nIdorsia Pharmaceuticals            20,33%      01.09.2020\nIdorsia Pharmaceuticals            11,97%      01.09.2020       \nJPMorgan, NY                      25,909%      28.08.2020\nJPMorgan, NY                      25,979%      27.08.2020\nJPMorgan, NY                      25,465%      26.08.2020\nJPMorgan Chase, NY                25,177%      20.08.2020 \nJPMorgan Chase, NY                 25,79%      13.08.2020  \nIdorsia Pharmaceuticals             9,39%      12.08.2020       \nSanthera Pharmaceuticals            \n- positions d'achat                 6,41%      13.07.2020\n- positions de vente               63,42%      13.07.2020\nCredit Suisse Group                 5,23%      01.07.2020\nSanthera Pharmaceuticals            \n- positions d'achat                 7,74%      29.06.2020             \n- positions de vente               64,32%      29.06.2020             \nFabrice Evangelista, Belgium\n- positions d'achat                32,19%      18.06.2020       \nSanthera Pharmaceuticals            \n- positions d'achat                 9,23%      16.06.2020\n- positions de vente               65,39%      16.06.2020\nJPMorgan \n- positions d'achat                28,74%      22.01.2019       \nSanthera Pharmaceuticals            \n- positions d'achat                 3,62%      03.06.2020\n- positions de vente               69,96%      03.06.2020\nSanthera Pharmaceuticals            \n- positions d'achat                 9,65%      14.04.2020       \n- positions de vente               48,96%      14.04.2020       \nFabrice Evangelista, Belgium\n- positions d'achat                41,01%      08.04.2020      \nFabrice Evangelista, Belgium \n- positions d'achat                42,99%      07.04.2020    \nSanthera Pharmaceuticals            \n- positions d'achat                10,77%      07.04.2020     \n- positions de vente               53,79%      07.04.2020    \nSanthera Pharmaceuticals            \n- positions d'achat                 0,52%      03.02.2020           \n- positions de vente               10,71%      03.02.2020       \nIglu Group (Gruppe Arnold)          2,97%      08.10.2019\nJPMorgan \n- positions d'achat                 2,95%      22.01.2019     \ngroupe Bertarelli                   7,12%      16.01.2019  \nJPMorgan \n- positions d'achat                 4,76%      21.12.2018\nJPMorgan                            3,01%      14.12.2018      \nSanthera Pharmaceuticals            \n- positions d'achat                 0,52%      19.12.2018            \n- positions de vente               18,14%      19.12.2018  \nRoderick Wong (RTW Fonds), US       2,79%      10.12.2018\nJPMorgan                            2,92%      22.11.2018\nSanthera Pharmaceuticals            \n- positions d'achat                 0,74%      21.11.2018      \n- positions de vente               25,76%      21.11.2018    \nSanthera Pharmaceuticals          \n- positions d'achat                 0,83%      20.11.2018   \n- positions de vente               45,02%      20.11.2018   \nIdorsia Pharmaceuticals            13,28%      23.11.2018  \nIdorsia Pharmaceuticals            15,32%      20.11.2018  \nRoderick Wong (RTW Fonds), US       4,99%      24.10.2018\nJPMorgan                            3,03%      17.08.2018\nGoldman Sachs                     0,0002%      15.08.2018\nGoldman Sachs                       5,37%      30.07.2018   \nGoldman Sachs                     0,0002%      09.07.2018\nGoldman Sachs                       6,61%      05.07.2018\nPolyphor AG                         2,81%      19.04.2018\nGoldman Sachs                       5,58%      16.04.2018       \nGoldman Sachs                     0,0002%      28.03.2018\nGoldman Sachs                      6,997%      28.02.2018\nSanthera Pharmaceuticals\n- positions d'achat                 0,57%      22.02.2018\n- positions de vente               26,69%      22.02.2018\ngroupe Bertarelli                   8,36%      22.02.2018\nIglu Group (Gruppe Arnold)          8,54%      22.02.2018\ngroupe Bertarelli                   8,36%      22.02.2018 \ngroupe Bertarelli                     &lt;3%      22.02.2018\nPolyphor AG                          3,8%      14.02.2018\nSanthera Pharmaceuticals\n- positions d'achat                 0,05%      14.02.2017  \n- positions de vente               29,36%      14.02.2017  \nGoldman Sachs                       0,01%      05.02.2018 \nNorges Bank                         2,04%      29.01.2018 \nNorges Bank                         3,09%      26.01.2018\nNorges Bank                            2%      19.01.2018\nNorges Bank                         3,41%      17.01.2018\nNorges Bank                         1,35%      05.01.2018\nGoldman Sachs                       7,28%      03.01.2018\nNorges Bank                         3,11%      04.01.2018\nGoldman Sachs                       0,01%      15.12.2017 \nGoldman Sachs                       5,35%      14.12.2017 \nUBS Fund Management (CH)              &lt;3%      16.11.2017\ngroupe Bertarelli                  17,57%      15.11.2017   \nGoldman Sachs                         &lt;3%      03.11.2017  \nNorges Bank                         2,02%      08.11.2017\nLagoda Investment Management          &lt;3%      02.11.2017 \nNorges Bank                         3,06%      07.11.2017\nNorges Bank                         2,77%      06.11.2017 \nNorges Bank                         3,25%      02.11.2017 \nGoldman Sachs                        6,1%      19.10.2017\nUBS Fund Management (Lux)             &lt;3%      18.09.2017  \nRenaissance Technologies, US            \n- positions de vente                2,99%      27.07.2017\nMark Angelo/YA Global Master          &lt;3%      02.02.2015 \nConsonance Capital, New York        2,74%      07.06.2017  \nRenaissance Technologies, US            \n- positions de vente                3,64%      19.05.2017\nConsonance Capital Management        4,9%      23.05.2017\nIglu Group, Zug/WHG Invest           \n(famille Bertarelli)               18,57%      17.05.2017\nRenaissance Technologies, US            \n- positions de vente                3,66%      27.02.2017   \nRenaissance Technologies, US             \n- positions de vente                3,01%      14.10.2016  \nRoderick Wong (RTW Fonds), US       5,04%      15.03.2017\nUBS Fund Management (Luxembourg)    3,39%      16.02.2017 \nSanthera Pharmaceuticals\n- positions d'achat                 0,05%      10.02.2017 \n- positions de vente               20,69%      10.02.2017\ngroupe Bertarelli                  18,84%      25.01.2017         \nfamille Bertarelli                    &lt;3%      25.01.2017        \nIglu Group, Zug                       &lt;3%      25.01.2017        \nUnion Investment                    2,81%      15.07.2016\nUBS Fund Management (CH)            3,11%      12.07.2016\nUBS Fund Management (CH)              &lt;3%      20.05.2016\nUnion Investment, DE                4,78%      13.04.2016 \nUBS Fund Management (Luxembourg)    2,93%      05.04.2016\nConsonance Capital Management, NY   9,53%      30.03.2016\nConsonance Capital Management, NY   9,99%      22.02.2016\nLagoda Investment Management     3,00006%      16.02.2016\nVisium Asset Management             2,87%      11.02.2016\nUnion Investment, DE                5,87%      29.12.2015\nUBS Fund Management (Luxembourg)   3,005%      07.12.2015\ngroupe CS/RBC/Bellevue                &lt;3%      04.12.2015  \nUBS Fund Management (CH))           3,15%      02.12.2015  \ngroupe CS/RBC/Bellevue              10,6%      01.12.2015\nUBS Fund Management                   &lt;3%      15.10.2015       \nUBS Fund Management                3,005%      05.10.2015        \nThomas Meier (CEO)                    &lt;3%      09.09.2015   \nConsonance Capital Management, NY  10,02%      09.07.2015        \nVisium Asset Management, NY         3,15%      02.07.2015  \nUnion Investment, DE                3,95%      16.04.2015      \nfamille Bertarelli                 10,97%      26.03.2015 \nThomas Meier (CEO)                  3,12%      17.03.2015        \nIglu Group, Zug                    14,32%      02.02.2015\nIglu Group, Zug                    15,57%      11.12.2014\nATP Early Harvest                   2,99%      09.09.2014 \nPura Vida Master Fund, New York     2,84%      29.08.2014\nNGN Capital LLC, USA                   3%      14.08.2014\nRTW Investments                     3,06%      06.08.2014\nATP Early Harvest Fund              4,01%      02.07.2014\nConsonance Capital Management, NY   6,01%      03.07.2014\nConsonance Capital Management, NY   4,14%      02.07.2014\nPura Vida Master Fund, New York        3%      27.06.2014         \nRudolf Maag (Varuma)                  &lt;3%      03.06.2014\nIglu Group, Zug                    15,37%      28.05.2014       \nATP Early Harvest Fund, New York    6,16%      19.05.2014\nIFM Independent Fund Management     2,86%      16.05.2014  \nHeidelberg Innovation BioScience    2,48%      28.03.2014\nSanthera Pharmaceuticals\n- positions d'achat                 2,75%      28.03.2014       \n- positions de vente               14,53%      28.03.2014       \nSanthera Pharmaceuticals\n- positions d'achat                 3,05%      04.03.2014\n- positions de vente               14,53%      04.03.2014\nSanthera Pharmaceuticals\n- positions d'achat                  k.A.      28.01.2014\n- positions de vente               23,91%      28.01.2014\nIglu Group (Arnold, K\u00fchnle etc.)    13,1%      27.02.2014\nRalf Arnold                           &lt;3%      26.02.2014\nSanthera Pharmaceuticals\n- positions de vente               23,91%      23.01.2014\nIFM Independent Fund, Vaduz         3,16%      04.11.2013 \nYA Global Master                   72,13%      30.10.2013  \nRalf Arnold                         5,78%      24.09.2013 \nRalf Arnold                         4,08%      25.06.2013\nNGN Capital LLC, USA                3,27%      09.04.2013\nBaker Bros. Life Sciences, USA        &lt;3%      20.03.2013\nBaker Bros. Life Sciences, USA      4,23%      15.03.2013\nBaker Bros. Life Sciences, USA      4,82%      14.03.2013\nMerlin General Partner II, UK       1,74%      17.09.2012 \nMerlin General Partner II, UK       4,78%      31.05.2012\nBaker Bros. Life Sciences, USA      5,21%      17.08.2011\nBaker Bros. Advisors, USA           3,08%      10.08.2011\nBaker Bros. Advisors, USA           3,05%      14.06.2011\nOBP, USA                              &lt;3%      07.01.2011    \nOBP, USA                            4,89%      17.11.2010\nNGN Capital LLC, USA                9,87%      01.06.2010 \nOppenheimer Funds Inc                 &lt;3%      03.06.2010       \nBertarelli/Ares Funds              14,94%      02.03.2010\nGIMV NV, Belgien                     4,3%      05.03.2010\nAllianz                               &lt;3%      30.07.2009\nCarnegie Fund II                      &lt;3%      02.07.2009\nBertarelli/Omega Funds             15,53%      14.05.2009\n3i Group, UK                          &lt;3%      14.05.2009\n3i Group, UK                        4,29%      20.03.2009     \nSchroders PLC                         &lt;3%      03.02.2009</pre>\n</div><p class=\"line-break\"><br/></p><p class=\"tr-copyright\">Copyright (c) 2021 Thomson Reuters Limited.</p></div>"}